Pfizer

With Covid Uncertainty Looming, is Pfizer a Buy for 2023?

With Covid Uncertainty Looming, is Pfizer a Buy for 2023?

Covid is Still a Global Problem The price of Pfizer stock is declining in the opening days of January as analysts prepare for the anticipated failure

On this website we use first or third-party tools that store small files (cookie) on your device. Cookies are normally used to allow the site to run properly (technical cookies), to generate navigation usage reports (statistics cookies) and to suitable advertise our services/products (profiling cookies). We can directly use technical cookies, but you have the right to choose whether or not to enable statistical and profiling cookies. Enabling these cookies, you help us to offer you a better experience.